Research on Influenza Viruses
Submission Deadline: 29 Feb 2024
Guest Editor
Laboratory of Influenza Research, College of Veterinary Medicine, Chungnam National University, Yuseong Gu, Daejeon, Republic of Korea
Interests: vaccine; epidemiology; pathogenicity on influenza virus and SARS-CoV-2
Special Issue in IMR Press journals
Special Issue in Vaccine and anti-viral drug development for SARS-CoV2
Special Issue Information
Dear Colleagues,
While influenza viruses have long caused a significant burden on humans and animals, new variants of influenza virus continue to emerge. Highly pathogenic H5NX and H7NX viruses infect domestic poultry, causing enormous economic losses to this industry. The current vaccine for human seasonal influenza viruses is available, but efficacy needs to be improved. To prepare for the next pandemic, the continuous surveillance in humans and animals, development of better vaccine for humans and animals, and study of the pathogenesis of potential pandemic viruses are all needed. In this special issue, research on vaccines, epidemiology, and pathogenesis to human and animal influenza viruses are welcomed.
Prof. Sang Heui Seo
Guest Editor
Keywords
- influenza virus
- vaccine
- pathogenicity
- epidemiology
- pandemic
Manuscript Submission Information
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted manuscripts should be well formatted in good English.
Published Papers (3)
UV-Inactivated rVSV-M2e-Based Influenza Vaccine Protected against the H1N1 Influenza Challenge
Front. Biosci. (Landmark Ed) 2024, 29(5), 195; https://doi.org/10.31083/j.fbl2905195
(This article belongs to the Special Issue Research on Influenza Viruses)
Host Cell-dependent Modulatory Role of Ras Homolog Enriched in Brain-Like-1 (RhebL1) Protein in Influenza A/NWS/33 Virus-infected Mammalian Cells
Front. Biosci. (Landmark Ed) 2024, 29(3), 116; https://doi.org/10.31083/j.fbl2903116
(This article belongs to the Special Issue Research on Influenza Viruses)
Apigenin’s Therapeutic Potential Against Viral Infection
Front. Biosci. (Landmark Ed) 2023, 28(10), 237; https://doi.org/10.31083/j.fbl2810237
(This article belongs to the Special Issue Research on Influenza Viruses)